Transformed T-Cell Non-Hodgkin Lymphoma

Transformed T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03380026	Mechlorethamine Induced Contact Dermatitis Avoidance Study(MIDAS)	completed	Phase 2	28	Rochester Skin Lymphoma Medical Group, PLLCOTHER	1	Sep 4, 2026	clinicaltrials
NCT04101331	Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides(REDIRECT)	completed	Phase 2	108	Affimed GmbHINDUSTRY	10	Nov 5, 2024